Autor: "Mereckiene, J." - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study.
Autorzy:: Savulescu C; Epidemiology Department, EpiConcept, Paris, France. Electronic address: .
Krizova P; Centre for Epidemiology and Microbiology, National Institute of Public Health, Prague, Czech Republic.
Lepoutre A; Infectious Disease Department, French National Agency for Public Health, Saint-Maurice, France.
Mereckiene J; Vaccine Preventable Disease Department, Health Protection Surveillance Centre, Dublin, Ireland.
Vestrheim DF; Department of Vaccine Preventable Diseases, Norwegian Institute of Public Health, Oslo, Norway.
Ciruela P; General Sub-Directorate for Surveillance and Public Health Emergency Response, Public Health Agency of Catalunya, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain.
Ordobas M; Sub-Directorate of Health Promotion and Prevention, Madrid, Spain.
Guevara M; Public Health Institute of Navarra-IdiSNA, Pamplona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain.
McDonald E; Health Protection Scotland, National Services Scotland, Glasgow, UK.
Morfeldt E; Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden.
Kozakova J; Centre for Epidemiology and Microbiology, National Institute of Public Health, Prague, Czech Republic.
Varon E; National Centre for Pneumococci, European Hospital George Pompidou, Paris, France.
Cotter S; Vaccine Preventable Disease Department, Health Protection Surveillance Centre, Dublin, Ireland.
Winje BA; Department of Vaccine Preventable Diseases, Norwegian Institute of Public Health, Oslo, Norway.
Munoz-Almagro C; CIBER Epidemiología y Salud Pública, Madrid, Spain; Molecular Microbiology Department, Hospital Sant Joan de Déu, Barcelona, Spain; International University of Catalunya, Barcelona, Spain.
Garcia L; Sub-Directorate of Health Promotion and Prevention, Madrid, Spain.
Castilla J; Public Health Institute of Navarra-IdiSNA, Pamplona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain.
Smith A; Scottish Haemophilus, Legionella, Meningococcus and Pneumococcus Reference Laboratory, Glasgow, UK.
Henriques-Normark B; Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden; Department of Microbiology, Tumour and Cell Biology, Karolinska Institute, Stockholm, Sweden; Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden.
Celentano LP; Office of Chief Scientist Unit, European Centre for Disease Prevention and Control, Stockholm, Sweden.
Hanquet G; Epidemiology Department, EpiConcept, Paris, France.; Pokaż więcej
Corporate Authors:: SpIDnet group
Źródło:: The Lancet. Respiratory medicine [Lancet Respir Med] 2017 Aug; Vol. 5 (8), pp. 648-656. Date of Electronic Publication: 2017 Mar 27.
Typ publikacji:: Journal Article; Multicenter Study; Observational Study
MeSH Terms:: Immunization Programs/*statistics & numerical data
Pneumococcal Infections/*epidemiology
Pneumococcal Infections/*prevention & control
Pneumococcal Vaccines/*therapeutic use
Child, Preschool ; Europe/epidemiology ; Female ; Humans ; Incidence ; Infant ; Male ; Outcome Assessment, Health Care ; Streptococcus pneumoniae/immunology

Czasopismo naukowe

na półce

Szczegóły

Informacja

Wyszukujesz frazę ""Mereckiene, J."" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Język